(资料图片仅供参考)
奥本海默将联合健康的目标价从405美元上调至420美元,维持“跑赢大市”评级。(格隆汇)
相关事件
2026-05-29
2026-05-28
2026-05-27
2026-05-26
2026-05-25
2026-05-23
2026-05-21
2026-05-20
2026-05-19
2026-05-18
2026-05-15
2026-05-14
2026-05-13
2026-05-12
2026-05-11
2026-05-10
2026-05-09
2026-05-08
2026-05-01
2026-04-27
2026-04-26
2026-04-25
2026-04-24
2026-04-23
2026-04-22
2026-04-21
2026-04-20
2026-04-17
2026-04-16
2026-04-15
2026-05-24
2026-05-22
2026-05-16